These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11874210)
1. Comparison between the effects of atypical and traditional antipsychotics on work status for clients in a psychiatric rehabilitation program. Meyer PS; Bond GR; Tunis SL; McCoy ML J Clin Psychiatry; 2002 Feb; 63(2):108-16. PubMed ID: 11874210 [TBL] [Abstract][Full Text] [Related]
3. Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics. Bond GR; Kim HW; Meyer PS; Gibson PJ; Tunis S; Evans JD; Lysaker P; McCoy ML; Dincin J; Xie H Psychiatr Serv; 2004 Jan; 55(1):59-66. PubMed ID: 14699202 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study. Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371 [TBL] [Abstract][Full Text] [Related]
6. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603 [TBL] [Abstract][Full Text] [Related]
7. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
8. Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective. Percudani M; Barbui C; Tansella M Pharmacoeconomics; 2004; 22(11):701-18. PubMed ID: 15250749 [TBL] [Abstract][Full Text] [Related]
9. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920 [TBL] [Abstract][Full Text] [Related]
11. Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment. McGurk SR; Mueser KT; Harvey PD; LaPuglia R; Marder J Psychiatr Serv; 2003 Aug; 54(8):1129-35. PubMed ID: 12883141 [TBL] [Abstract][Full Text] [Related]
12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
13. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment. Kaneda Y; Jayathilak K; Meltzer H Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677 [TBL] [Abstract][Full Text] [Related]
14. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209 [TBL] [Abstract][Full Text] [Related]
15. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods. Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765 [TBL] [Abstract][Full Text] [Related]
16. [Metabolic side effects of risperidone in early onset schizophrenia]. Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I; J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069 [TBL] [Abstract][Full Text] [Related]